Universidad de valladolid, Spain ; Inserm U. 188, Paris. Somatomedin and transferrin in celiac disease (CD).
Sulfation activity (Sm) and transferrin (Tf) were measured in 90 plasma samples from 39 children with CD classified 5 to 1 by intestinal biopsy performed at time of sampling : 10 before, 58 during gluten-free diet (GF), 22 after gluten reintroduction (GR). Sm was 0.32 ± 0.04 U/ml before GF, increased with GF from stages 5 to 1, to reach 1.23 ± 0.15, decreased at GR to 0.38 ± 0.06. Sm correlated to GF duration (r = 0.781).
Correlation of Sm with growth velocity (V) was lacking at stages 5 to 2, and appeared at stage 1 (r = 0.778).
Tf decreased from a high value of 3.62 ± 0.15 gil at stage 5 to 2.97 ± 0.14 after GF at stage 1, rising to 3.35 ± 0.10 at GR. Tf correlated negatively with GF duration (r = -0.720) and positively to V on GF (r = 0.492) and GR (r = 0.601) • Longitudinal studies from GF to GR and again GF confirmed the inverse trend of sm and Tf variations. These data show that early catch-up growth in CD treated with GF does not relate to sulfation activity and may involve other factor~such as Tf. Random plasma somatomedln-C I.v.ls w.re measur.d In lDl chlldr.n ag.d 7 months to 18 years with growth at or below the 5th percentile. 87 of 1Dl had short stature due to constitutional delay or gen.tlc predisposition and 14 were growth hormone defIcient. In the short normal group mean somatomedln-C l.vels wer.: D-2 years: 0.22! 0.02U/ml; 2-5 years: 0.28tO.06U/ml; 5-12 years: 0.78±O.IU/ml; 12-18 y.ars: 1.22±O.16U/ml; compared wIth 0.23±O.04U/ml In the growth harmon. deflcl.nt children. 55 of 101 had somatomedln-C I.v.ls of 0.5U/ml, and had one or more growth harmon. stimulation t.sts. All 14 growth hormone deficIent patl.nts f.II Into this group (range: 0.09-0.47U/ml). Th. 41 normal patl.nts In this group (growth hormona 6ng/ml) were dlstlbut.d among the .ntlre 87 normals as follows: 0-2 y.ars: 10/10; 2-5 y.ars: 19/23; 5-12 y.ars: 11130; 12-18 years: 1/24. There was cons Id.rab I. overlap of values among growth hol'lllOlle deflcl.nt and short normal children under 12 years of age, but a cl.ar separation above 12 y.ars. In 5 of 6 patl.nts In whom 2 measurements were mad., th.re were major dl ff.r.nces In these I.ve Is. 1) Random somatomedln-C l.vels lack specIficity In scr••nlpg for growth hormone deflcl.ncy und.r the age of 12 y.ars. 2) Th. variation of l.v.ls In Individual patl.nts n.cessltat.s furth.r study to Identify a possible diurnal or pulsatll. secr.tory patt.rn. 3) A standardlz.d time of sampling should be conslder.d. 
Drugs commonly used to tr.at children with acut. lymphoblastic leuka.mia were inv.stigated in vitro to determine cartilage responsiv.n.ss to aomatom.din using the uptake of radioactive sulphate and thymi din. by porcine cartilage.
Prednisolone and doxorubicin profoundly d.press cartilag. r.sponsiv.n.ss at dos.s within therapeutic ranges and vincristine and cytosin. arabinoside produc. less.r but significant inhibition.
Using Acute and chronic somatomedin-C response to growth hormone: evaluation of correlation with age and growth rate.
The correlation between acute and chronic SM-C responses to hGH treatment of hypopituitary dws.rfism, snd their value in predicting growth rates were studied in 20 GH-deficient children. SM-C by RIA and RRA was measured prior to hGH, 12 hours after 4 daily injections of hGH, 0.1 U/kg, and after 6 months of hGH 0.1 U/kg t.i. The correlation between SM-C by RRA and RIA was highly significant (roO.92 on Day 1 and at 6 months, p < 0.001). The acute SM-C response to hGH was predictive of chronic SM-C levels (Day 5 vs. 6 month SM-C, roO.80, p <0.001). However, individual SM-C responses were variable, with 7 children achieving SM-C levels >1 U/ml by Day 5, while 3 maintained levels < 0.10 U/ml. Although the annual growth rate increased from 3.6 + 0.1 to 6.7 + 0.6 cm/yr, no correlation was observed between growth rate and baseline, acute or chronic SM-C levels. Children under 10 years of age had the smallest increment in SM-C, but the best growth rate. However, even when subdivided by age, no correlation was observed between 6 month SK-C and growth rates (roO.lO, p >0.75) . We conclude that (1) the acute SK-C response to hGH predicts chronic SM-C levels, (2) SM-C and growth response to hGH are age-dependent and (3) the level of SM-C elevation with hGH cannot predict growth response.
Effects of fasting and refeedinq on grbwth hormone receptors inrat liver membranes.
The mechanism of the growth defect often associated with poor nutrition is not clear. We have studied the specific binding of growth hormone (GH) to liver membranes of 3 groups of rats which were (F) fasted for 4 days, (R) refed for 3 days after fasting. ana (controls) allowed free access to food. The specific binding of 125I-BGH (bovine GH) was low in microsomal membranes of (F) rats , 57 , that of controls. The number of somatotropic sites rather than the affinity of the binding was affected. The lactogenic sites as judged on the binding of l25I-HGH (human GH) were not significantly reduced in membranes of (F) rats. The number of insulin receptors was elevated in microsomal membranes of (F) rats : 185 , that of controls ; this modification was associated with a decreased insulinemia in (F) rats. But no change of the plasma GH was found in (F) and (R) rats when compared to controls; other factor(s) than the hormone level must regulate the somatotropic sites in this model. Refeeding led to a correction of the binding of 125I-BGH and of 125I-Insulln to microsomal membranes. Decreased plasma somatomedin bioactivity was~ssociated with the low number of somatotropic receptors in the liver membranes of fasted rats ; it suggests a role of the GH liver receptors in the regulation of the plasma somatomedin activity.
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